Lusedra

Lusedra

Lusedra Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

LUSEDRATM (fospropofol disodium) injection is an intravenous sedative-hypnotic agent indicated for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.

History

There is currently no drug history available for this drug.

Other Information

LUSEDRA is an injection solution intended for intravenous administration as a sedative-hypnotic agent. LUSEDRA is an aqueous, sterile, nonpyrogenic, clear, colorless, iso-osmotic solution containing 35 mg/mL of fospropofol disodium. Fospropofol disodium is a water-soluble prodrug of propofol, chemically described as 2,6-diisopropylphenoxymethyl phosphate, disodium salt. The structural and molecular formulas are shown in Figure 1.


lusedra-01

Molecular Formula: C13H19O5PNa2
Molecular Weight: 332.24
Figure 1. Structural and Molecular Formulas of Fospropofol Disodium

The inactive components include monothioglycerol (0.25 wt%) and tromethamine (0.12 wt%). LUSEDRA has a pH of 8.2 to 9.0. LUSEDRA does not contain any antimicrobial preservatives and is intended for single-use administration.

Lusedra Manufacturers


  • Eisai, Inc
    Lusedra (Fospropofol Disodium) Injection [Eisai, Inc]

Login To Your Free Account